Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **mitochondrial fatty acid transport machinery** encompasses the molecular systems that mediate the transfer of fatty acids from storage sites (e.g., lipid droplets) into mitochondria for their oxidation and conversion into cellular energy[4][6]. This machinery operates at the interface of lipid droplets, mitochondria, and the endoplasmic reticulum, involving transport proteins (such as CPT1/2), acyl-CoA synthetases, and structural contact site proteins (ESYT1, VAPB, PLIN5, etc.), which collectively regulate fatty acid flux, support energy production, and maintain lipid homeostasis[4][6]. Dysregulation of this machinery is implicated in metabolic diseases, cardiovascular disease, cancer, and other disorders, making it a pharmacologically relevant composite target, though not a single molecule[3][4][6].
Inhibition of fatty acid import (e.g., CPT1 inhibitors block entry of long-chain fatty acids) Modulation of lipid utilization and mitochondrial β-oxidation for energy metabolism
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial fatty acid transport machinery (None widely accepted; "mtFAT machinery" is sometimes used in literature, but no universally recognized abbreviation exists[1][2].).